TACE/HAIC

PROCEDURE2 trials

Sponsors

Third Affiliated Hospital, Sun Yat-Sen University, Shanghai Zhongshan Hospital

Conditions

Hepatocellular Carcinoma

Phase 2

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Third Affiliated Hospital, Sun Yat-Sen UniversityHepatocellular Carcinoma

Start: 2022-05-30End: 2024-12-30Target: 90Updated: 2023-10-13

Unknown Phase

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Not yet recruitingNCT06423144

Shanghai Zhongshan HospitalHepatocellular Carcinoma

Start: 2024-05-31End: 2024-10-31Target: 150Updated: 2024-05-21